Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY) stock analysis

ALNY · Alnylam Pharmaceuticals, Inc. - Common Stock

Latest recorded price: USD 159.73

Sector and industry: Healthcare · Biotechnology

A reliable intrinsic value could not be calculated for ALNY; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 53.0%, free cash flow margin 12.5%. The model flags 1 risk signal for this company.

Similar companies in Healthcare